Bahrain is actively participating in the UAE's phase III clinical trials for the COVID-19 vaccine.
According to Ashish Koshy, the CEO of G42 Healthcare, Bahrain is working on enrolling and vaccinating close to 6,000 volunteers.
He clarified that this expansion enforces the ongoing collaboration between the two countries.
Speaking to ARN News, Koshy revealed that there will be more collaborations in the future.
He explained that the current trials have also shown positive results so far.
Emirates Global Aluminium reports significant damage after attack
UAE air defences engage 20 ballistic missiles, 37 UAVs
Gargash urges political approach to regional security
Dubai Police handles 56,000 emergency calls during bad weather
UAE authorities confirm weather conditions now stable in region
